Modulators of Nuclear Receptor Co-regulatory Protein Binding

Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling, methods for inhibiting the interaction between a co-regulatory protein and an androgen or estrogen receptor, and methods for treating cancer.

Patents:
US 20,110,105,608

Inventor(s): HANSON ROBERT N [US]

Type of Offer: Licensing



« More Biotech Patents

---